{"id":"CHEMBL1047","canonicalSmiles":"CC(=O)Oc1c(C)c(C)c2c(c1C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"ZAKOWWREFLAJOT-CEFNRUSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCOPHEROL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205044","144205117","144207016","144213754","170465444","29218011","57264399"],"Wikipedia":["Tocopheryl_acetate"],"drugbank":["DB14002"],"chEBI":["32321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1082607","canonicalSmiles":"O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O","inchiKey":"XTZNCVSCVHTPAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALMETEROL XINAFOATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1263","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Serevent"],"synonyms":["GR 33343 G","GR-33343 G","GR-33343X","LIPO-202","Salmeterol 1-hydroxy-2-naphthoate","Salmeterol xinafoate"],"crossReferences":{"DailyMed":["salmeterol%20xinafoate"],"PubChem":["144204822","170465397","26753648","29215171","50107004","56320805","56320806","90341116"]},"count":5,"approvedIndications":["EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000270","EFO_0000464","EFO_0006505","EFO_0010638","EFO_0000341","EFO_0001073"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1088751","canonicalSmiles":"CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1","inchiKey":"KCAJXIDMCNPGHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PH-797804","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PH-797804","PHA-797804","Ph-797804"],"crossReferences":{"PubChem":["103905624","137276009"],"drugbank":["DB07941"],"chEBI":["82715"]},"count":4,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506","EFO_0006510","EFO_0000341","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1090","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OIRDTQYFTABQOQ-UHTZMRCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIDARABINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vira-a"],"synonyms":["ARA-A","Arabinosyladenine","CI 673","CI-673","NSC-247519","NSC-404241","Vidarabine","Vidarabine monohydrate"],"crossReferences":{"PubChem":["11112564","47193870"],"Wikipedia":["Vidarabine"],"drugbank":["DB00194"],"chEBI":["45327"]},"count":2,"approvedIndications":["EFO_1001888","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for eye infection and viral disease."}
{"id":"CHEMBL1096","canonicalSmiles":"CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1","inchiKey":"SGRYPYWGNKJSDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMLEXANOX","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amlexanox","Aphthasol"],"synonyms":["AA-673","Amlexanox","CHX 3673","CHX-3673"],"crossReferences":{"PubChem":["124893315","144206029","170465365","26719859","50112726"],"Wikipedia":["Amlexanox"],"drugbank":["DB01025"],"chEBI":["31205"]},"count":2,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["HP_0006536","EFO_1001904"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for airway obstruction and has 1 investigational indication."}
{"id":"CHEMBL1097615","canonicalSmiles":"CC#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]c1=O","inchiKey":"QLOCVMVCRJOTTM-SDNRWEOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETIVUDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["882C-87","882C87","Netivudine"],"crossReferences":{"drugbank":["DB12606"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1160594","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1I","inchiKey":"WXFYBFRZROJDLL-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160594","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02324"]},"childChemblIds":["CHEMBL572275"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116296","canonicalSmiles":"Ic1ccccc1","inchiKey":"SNHMUERNLJLMHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOBENZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodo-Benzene","Iodobenzene"],"crossReferences":{"Wikipedia":["Iodobenzene"],"drugbank":["DB02252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1199540","canonicalSmiles":"O=C(C[C@H]1NCCC[C@@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"LVASCWIMLIKXLA-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Halofuginone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halofuginone"],"crossReferences":{"Wikipedia":["Halofuginone"],"drugbank":["DB04866"]},"childChemblIds":["CHEMBL1162015"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200382","canonicalSmiles":"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1.Cl.O","inchiKey":"UEECHQPWQHYEDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPRIDIL HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1008","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepadin","Vascor"],"synonyms":["Bepridil hydrochloride","CERM 1978","CERM-1978"],"crossReferences":{"chEBI":["52715"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200555","canonicalSmiles":"CN(C(=O)CC(=O)N(C)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I)c1c(I)c(C(=O)NC(CO)C(O)CO)c(I)c(C(=O)NC(CO)C(O)CO)c1I","inchiKey":"XUHXFSYUBXNTHU-UHFFFAOYSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"IOTROLAN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Osmovist","Osmovist 190","Osmovist 240"],"synonyms":["Iotrol","Iotrolan","ZK 39 482","ZK-39482"],"crossReferences":{"Wikipedia":["Iotrolan"],"drugbank":["DB09487"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1200625","canonicalSmiles":"[89Sr+2].[Cl-].[Cl-]","inchiKey":"AHBGXTDRMVNFER-FCHARDOESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM CHLORIDE SR 89","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2219640","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metastron","Strontium chloride sr-89"],"synonyms":["89sr","SMS-2PA","SMS2PA","Strontium (89 sr) chloride","Strontium (89Sr) Chloride","Strontium (89sr) chloride","Strontium chloride sr 89","Strontium chloride sr-89"],"crossReferences":{"DailyMed":["strontium%20chloride%20sr-89"],"drugbank":["DB09498"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and has 1 investigational indication."}
{"id":"CHEMBL1200670","canonicalSmiles":"CC(=O)O.CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C.O","inchiKey":"YBZYNINTWCLDQA-UHKVWXOHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SARALASIN ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL938","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sarenin"],"synonyms":["P-113","Saralasin acetate"],"crossReferences":{"Wikipedia":["Saralasin"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200788","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC.O","inchiKey":"QBYYXIDJOFZORM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CISAPRIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1729","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Propulsid","Propulsid Quicksolv"],"synonyms":["Cisapride Monohydrate","Cisapride monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200794","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl","inchiKey":"BCGJBQBWUGVESK-KCTCKCTRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYMORPHONE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL963","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Numorphan","Opana","Opana er","Oxymorphone hydrochloride"],"synonyms":["Oxymorphone hydrochloride"],"crossReferences":{"DailyMed":["oxymorphone%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["HP_0012532","EFO_0003843","EFO_0007490"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for pain. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200933","canonicalSmiles":"C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21.[Br-].[Br-]","inchiKey":"WDEFPRUEZRUYNW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAFLUORENIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201349","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mylaxen"],"synonyms":["Hexafluorenium bromide","Hexaflurone bromide","Hexafluronium bromide"],"crossReferences":{"PubChem":["144206765"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200974","canonicalSmiles":"CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"GVNWHCVWDRNXAZ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBINOXAMINE MALEATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL864","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbinoxamine maleate","Clistin","Davenol","Karbinal er"],"synonyms":["Carbinoxamine maleate"],"crossReferences":{"DailyMed":["carbinoxamine%20maleate"],"PubChem":["144205889","170465237","26749308","93576626"],"chEBI":["31353"]},"count":6,"approvedIndications":["EFO_0005531","EFO_0007533","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007533","EFO_0007141","EFO_0005532","EFO_1001417","EFO_0003956"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 6 approved indications."}
{"id":"CHEMBL1201047","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.Cl","inchiKey":"UDUQHZSAAWGSPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANILERIDINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201347","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leritine"],"synonyms":["Anileridine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201104","canonicalSmiles":"C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1","inchiKey":"ROAIXOJGRFKICW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHENAMINE HIPPURATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201270","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hiprex","Methenamine hippurate","Urex"],"synonyms":["Hexamine hippurate","Methenamine hippurate"],"crossReferences":{"DailyMed":["methenamine%20hippurate"]},"count":2,"approvedIndications":["EFO_0003103"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for urinary tract infection and has 1 investigational indication."}
{"id":"CHEMBL1201112","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"IXOXBSCIXZEQEQ-UHTZMRCNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NELARABINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arranon","Atriance"],"synonyms":["506U","506U78","GW-506U78","MAY","NSC-686673","Nelarabine","Nelzarabine"],"crossReferences":{"DailyMed":["nelarabine"],"PubChem":["144206267","170464759"],"Wikipedia":["Nelarabine"],"drugbank":["DB01280"],"chEBI":["63612"]},"count":13,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for neoplasm and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201234","canonicalSmiles":"CNC(C)(C)Cc1ccccc1","inchiKey":"RXQCGGRTAILOIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENTERMINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mephentermine"],"crossReferences":{"PubChem":["11112475"],"Wikipedia":["Mephentermine"],"drugbank":["DB01365"],"chEBI":["6755"]},"childChemblIds":["CHEMBL3184799","CHEMBL1200996"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1201392","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"WXURHACBFYSXBI-GQKYHHCASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMETHASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumetasone","Flumethasone","U-10,974","U-10974"],"crossReferences":{"PubChem":["144204069","170465750","56422164","855624"],"Wikipedia":["Flumetasone"],"drugbank":["DB00663"],"chEBI":["34764"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201558","drugType":"Protein","blackBoxWarning":true,"name":"INTERFERON ALFA-2B","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intron a","Intron a hsa-free","Intron-A","Viraferon"],"synonyms":["Interferon alfa-2b","SCH 30500","SCH-30500"],"crossReferences":{"DailyMed":["interferon%20alfa-2b"],"DrugCentral":["5205"],"Wikipedia":["Interferon_alfa-2b"]},"count":31,"approvedIndications":["EFO_0004220","EFO_0000558","EFO_1000956","EFO_0000756","EFO_0000389","MONDO_0018906","EFO_0004197","EFO_0004239","EFO_0007147"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0019471","EFO_0000558","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_0007147","EFO_0000565","EFO_0000339","EFO_1000956","EFO_0000544","EFO_0000389","EFO_0000182","EFO_0000673","EFO_0001668","EFO_0003047","EFO_0000616","EFO_0002618","MONDO_0004658","MONDO_0024503","MONDO_0008170","EFO_0000349","EFO_0004197","MONDO_0008315","EFO_0000311","EFO_0009708","EFO_0004239","MONDO_0002691","EFO_0001422","EFO_0004220","EFO_0007306","MONDO_0100096","MONDO_0000544","EFO_0000764","EFO_0000574","MONDO_0002367","EFO_1001051","MONDO_0018906","EFO_0001378"],"count":39},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 9 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201785","canonicalSmiles":"CCCCCCOC(=O)CCC(=O)CN.Cl","inchiKey":"LZYXPFZBAZTOCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMINOLEVULINATE HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201784","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cysview kit","Hexvix"],"synonyms":["Hexaminolevulinate hydrochloride","P-1026","P-1206"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2010 and has 1 investigational indication."}
{"id":"CHEMBL120563","canonicalSmiles":"CN(C)C(=S)SSC(=S)N(C)C","inchiKey":"KUAZQDVKQLNFPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rezifilm"],"synonyms":["NSC-1771","SQ 1489","Thiram"],"crossReferences":{"PubChem":["11532980","144204701","144208767","144211419","170465664","17389717","26747381","26753057","490901","68535"],"drugbank":["DB13245"],"chEBI":["9495"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1213456","canonicalSmiles":"COc1c(N2C[C@@H](C)C[C@H](N)C2)ccc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"AVPQPGFLVZTJOR-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEMONOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nemonoxacin","TG-873870"],"crossReferences":{"drugbank":["DB06600"]},"childChemblIds":["CHEMBL1213283"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1230314","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O","inchiKey":"AJIPIJNNOJSSQC-NYLIRDPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTETROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-4","E4","Estetrol","Estetrol (anhydrous)"],"crossReferences":{"drugbank":["DB12235"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1231329","canonicalSmiles":"O=C(O)c1c(C(=O)O)c(C(=O)O)c(C(=O)O)c(C(=O)O)c1C(=O)O","inchiKey":"YDSWCNNOKPMOTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELLITIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzenehexacarboxylic Acid","Mellitic Acid"],"crossReferences":{"drugbank":["DB01681"],"chEBI":["41089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231859","canonicalSmiles":"NC(=O)c1cncc([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"UINNILASBHZOTM-KMXXXSRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231859","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233851","canonicalSmiles":"O=C1N[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N2C1=O","inchiKey":"OIURYJWYVIAOCW-PQMKYFCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KIFUNENSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kifunensine"],"crossReferences":{"drugbank":["DB02742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235122","canonicalSmiles":"C[C@]12C[C@@]34CCC(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2","inchiKey":"XADCWKSMHQPTGH-OFBLZTNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08366"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235161","canonicalSmiles":"C[N+](C)(C)CCOP(=O)(O)O","inchiKey":"YHHSONZFOIEMCP-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOCHOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphocholine"],"crossReferences":{"drugbank":["DB03945"],"chEBI":["18132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1335406","canonicalSmiles":"Cc1cc(C)c(NC(=O)C[C@H](CC(=O)[O-])c2cccc3ccccc23)c(C(=O)N2CCC3(CCCC3)CC2)c1.[Na+]","inchiKey":"POCBIGAWFDIUCL-VQIWEWKSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1335406","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1256717","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112038","144204791","50106531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1339","canonicalSmiles":"CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.Cl","inchiKey":"XCMULUAPJXCOHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARDENAFIL HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1520","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levitra","Staxyn","Vardenafil hydrochloride"],"synonyms":["BAY 38-9456","BAY-38-9456","Vardenafil hydrochloride","Vardenafil hydrochloride anhydrous","Vardenafil hydrochloride hydrate","Vardenafil hydrochloride trihydrate"],"crossReferences":{"DailyMed":["vardenafil%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0004234"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for erectile dysfunction."}
{"id":"CHEMBL14","canonicalSmiles":"C[N+](C)(C)CCOC(N)=O.[Cl-]","inchiKey":"AIXAANGOTKPUOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBACHOL","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL965","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbachol","Carbastat","Doryl","Miostat"],"synonyms":["Carbachol","Carbacholine Chloride","Carbacholine chloride","Carbamoylcholine chloride"],"crossReferences":{"PubChem":["144205582","170464972","26747465","50105987","56463323"],"Wikipedia":["Carbachol"],"chEBI":["3385"]},"count":1,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972 and is indicated for glaucoma."}
{"id":"CHEMBL1421","canonicalSmiles":"Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1","inchiKey":"ZBNZXTGUTAYRHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASATINIB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib hydrate","Dasatinib monohydrate"],"crossReferences":{"DailyMed":["dasatinib"],"PubChem":["103905543","124893650","124893651","124893652","144206289","164339436","170465390","50100097","50125840"],"Wikipedia":["Dasatinib"],"drugbank":["DB01254"],"chEBI":["49375"]},"count":73,"approvedIndications":["EFO_0000616","MONDO_0000873","EFO_0000220","MONDO_0000870","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000157404","ENSG00000113721","ENSG00000142627","ENSG00000010810","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000097007","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000197122"],"count":14},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0003869","EFO_0000756","EFO_0000249","EFO_1000657","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1001935","EFO_0000339","EFO_0000588","EFO_1000956","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0003884","EFO_0002918","EFO_1000785","EFO_0009441","EFO_0000198","EFO_0002618","MONDO_0001852","MONDO_0019465","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0002429","MONDO_0008315","EFO_0005221","EFO_1000026","MONDO_0015917","MONDO_0019474","EFO_0003032","MONDO_0019472","EFO_0000574","EFO_1001051","EFO_0001378","EFO_1000550","EFO_1002001","MONDO_0019471","MONDO_0003175","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_1000475","EFO_0000255","EFO_1001469","EFO_0000708","MONDO_0002087","MONDO_0003541","MONDO_0021063","EFO_1001480","MONDO_0002158","EFO_1000044","MONDO_0044743","EFO_0000770","EFO_0004289","EFO_0000673","EFO_0000196","EFO_1001993","EFO_0000183","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0006859","MONDO_0019457","EFO_0000403","Orphanet_44890","MONDO_0016586","EFO_0000222","MONDO_0000870","MONDO_0019469","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000095","MONDO_0011962","EFO_1001936","EFO_0000191","EFO_0000702","MONDO_0018906","EFO_0003833","MONDO_0024880","MONDO_0004643","EFO_0000519","EFO_0000181"],"count":87},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 68 investigational indications."}
{"id":"CHEMBL1451116","canonicalSmiles":"IC(I)I","inchiKey":"OKJPEAGHQZHRQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOFORM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodoform","NSC-26251"],"crossReferences":{"PubChem":["144204675","144209587","144213091","17389850","26752992"],"Wikipedia":["Iodoform"],"drugbank":["DB13813"],"chEBI":["37758"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1503","canonicalSmiles":"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1","inchiKey":"SUBDBMMJDZJVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEPRAZOLE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antra","Losec","Losec mups","Mezzopram","Mopral","Omeprazole","Omeran","Prilosec","Zanprol"],"synonyms":["H 168/68","H-168/68","Omeprazole"],"crossReferences":{"DailyMed":["omeprazole","omeprazole%20magnesium"],"PubChem":["104171331","11112840","124882676","124882677","144204237","144207707","170465443","174007234","26751452","26751453","50103932","56422106","855576"],"TG-GATEs":["12"],"Wikipedia":["Omeprazole"],"drugbank":["DB00338"],"chEBI":["77260"]},"childChemblIds":["CHEMBL2105294","CHEMBL1567328"],"count":61,"approvedIndications":["HP_0004398","EFO_0009454","EFO_0003948","EFO_0000544","EFO_0004607"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0002239","HP_0012735","EFO_0000249","EFO_0004274","HP_0003073","EFO_1001951","EFO_0002506","Orphanet_98869","EFO_0000544","EFO_0000676","HP_0003419","MONDO_0015277","EFO_1000961","HP_0001601","EFO_0000400","EFO_1001250","EFO_1000874","EFO_0003756","HP_0012532","EFO_0000180","EFO_0004607","EFO_0007549","EFO_0000384","MONDO_0008315","MONDO_0003523","MONDO_0001684","EFO_0009130","EFO_0000546","MP_0001914","EFO_0004232","EFO_0005741","EFO_0001359","EFO_0000574","EFO_0000341","EFO_0000516","EFO_0001360","EFO_0003767","EFO_0005672","EFO_1001095","EFO_1000172","EFO_0004234","EFO_0000768","MONDO_0007254","Orphanet_586","MONDO_0043839","EFO_0000274","EFO_0000305","EFO_0003948","HP_0004398","MONDO_0001056","Orphanet_68380","EFO_0009462","EFO_0004272","EFO_0007231","EFO_0003047","EFO_0002617","EFO_0000616","EFO_0000280","EFO_0000685","EFO_0006859","EFO_0001645","EFO_0003898","EFO_0003929","EFO_0007512","EFO_0003843","EFO_1001355","EFO_0000311","EFO_0008533","EFO_0009784","EFO_0009454","EFO_0004220","EFO_0000764","EFO_0000191","EFO_0000199","EFO_0000181","MONDO_0024475"],"count":77},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 5 approved and 56 investigational indications."}
{"id":"CHEMBL1515611","canonicalSmiles":"CC(C)C(Br)C(=O)NC(N)=O","inchiKey":"CMCCHHWTTBEZNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMISOVALUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bromural"],"synonyms":["Bromisoval","Bromisovalum","Bromovaluree","Bromvalerylurea"],"crossReferences":{"PubChem":["144205368","170465828","29216126"],"Wikipedia":["Bromisoval"],"drugbank":["DB13370"],"chEBI":["77043"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15571","canonicalSmiles":"c1nc[nH]n1","inchiKey":"NSPMIYGKQJPBQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2,4-TRIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,4-Triazole","1H-1,2,4-Triazole","4H-[1,2,4]Triazole"],"crossReferences":{"PubChem":["144210433"],"Wikipedia":["1,2,4-Triazole"],"drugbank":["DB03594"],"chEBI":["46077"]},"childChemblIds":["CHEMBL1377189"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1567463","canonicalSmiles":"C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO","inchiKey":"SUHOQUVVVLNYQR-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE ALFOSCERATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Choline alfoscerate","Choline glycerophosphate"],"crossReferences":{"PubChem":["855725"],"Wikipedia":["Alpha-GPC"],"drugbank":["DB04660"],"chEBI":["16870"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1592","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O","inchiKey":"JSDRRTOADPPCHY-HSQYWUDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINAPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C09AA06","CI-906","Quinapril"],"crossReferences":{"DailyMed":["quinapril%20hydrochloride"],"Wikipedia":["Quinapril"],"drugbank":["DB00881"],"chEBI":["8713"]},"childChemblIds":["CHEMBL1201011"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000319","EFO_0000537","MONDO_0001299"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991 and is indicated for cardiovascular disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1601669","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"OFHCOWSQAMBJIW-AVJTYSNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFACALCIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alfa d","Etalpha","One-alpha"],"synonyms":["1.alpha.-hydroxycholecalciferol","Alfacalcidol"],"crossReferences":{"PubChem":["50125753"],"drugbank":["DB01436"],"chEBI":["31186"]},"count":8,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0002970","EFO_1001173","EFO_0000401","EFO_0004278","EFO_0003882","EFO_1002048","EFO_0000660","EFO_0002690","EFO_0000544","EFO_0003854","EFO_0000270","EFO_0003884","EFO_0004273","EFO_0003837"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1625750","canonicalSmiles":"Cc1ccc(S(=O)(=O)NCl)cc1","inchiKey":"NXTVQNIVUKXOIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAMINE-T","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloramine-t"],"crossReferences":{"drugbank":["DB14708"],"chEBI":["53782"]},"childChemblIds":["CHEMBL1591636","CHEMBL1697734","CHEMBL4303314","CHEMBL3186336"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1699","canonicalSmiles":"CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl","inchiKey":"LDDHMLJTFXJGPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEMANTINE HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL807","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akatinol","Ebixa","Marixino","Memantine","Memantine hydrochloride","Namenda","Namenda xr","Nemdatine","Valios"],"synonyms":["FP-01","Memantine hydrochloride","NSC-102290","SUN-Y7017"],"crossReferences":{"DailyMed":["memantine%20hydrochloride"],"PubChem":["26747595","50106707","50106708","57260151"],"chEBI":["64323"]},"count":11,"approvedIndications":["HP_0000726"],"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003888","Orphanet_282","Orphanet_232","HP_0200134","HP_0000726","EFO_0000249","EFO_1001465","EFO_0003758","EFO_0003757","EFO_0009267","EFO_0000326","EFO_1001488","EFO_0007328","EFO_0000253","EFO_0004699","MONDO_0004681"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for dementia and has 10 investigational indications."}
{"id":"CHEMBL1700","canonicalSmiles":"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1.Cl","inchiKey":"VIDRYROWYFWGSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOTALOL HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL471","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-cardone","Betapace","Betapace af","Sorine","Sotacor","Sotalex","Sotalol hydrochloride","Sotylize"],"synonyms":["DL-MJ-1999","MJ 1999","MJ-1999","Sotalol hydrochloride"],"crossReferences":{"DailyMed":["sotalol%20hydrochloride"],"PubChem":["144204819","26719708","46500431","50106953"],"chEBI":["9207"]},"count":2,"linkedTargets":{"rows":["ENSG00000055118","ENSG00000169252","ENSG00000043591"],"count":3},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL170179","canonicalSmiles":"CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHADYL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acemethadone","Acetylmethadol","Alphacetylmethadol","Methadyl acetate"],"crossReferences":{"drugbank":["DB01433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1705709","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FEREDETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sytron"],"synonyms":["Sodium feredetate","Sodium ironedetate"],"crossReferences":{"DrugCentral":["4709"],"PubChem":["144205670","144209121","144213753","170464680","26757848"],"chEBI":["78292"]},"count":1,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for anemia (phenotype)."}
{"id":"CHEMBL172513","canonicalSmiles":"C[N+](C)(C)CC(O)CC(=O)[O-]","inchiKey":"PHIQHXFUZVPYII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARNITINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carnitine","Carnitine chloride","Carnitine dl-form"],"crossReferences":{"Wikipedia":["Carnitine"],"chEBI":["17126"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1742992","drugType":"Antibody","blackBoxWarning":true,"name":"BLINATUMOMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Blinatumomab","MEDI-538","MT-103"],"crossReferences":{"DailyMed":["blinatumomab"],"DrugCentral":["4915"]},"count":12,"approvedIndications":["EFO_0000616","EFO_0000220"],"linkedTargets":{"rows":["ENSG00000167286","ENSG00000177455","ENSG00000160654","ENSG00000198851"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000873","EFO_0000220","EFO_0001642","EFO_0000403","EFO_0000209","EFO_0005952","MONDO_0003541","EFO_0000565","EFO_1001935","MONDO_0020511","EFO_0000095","EFO_0000574","EFO_0001378","MONDO_0020743","EFO_0000094","MONDO_0002083"],"count":17},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for acute lymphoblastic leukemia and neoplasm and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743037","drugType":"Antibody","blackBoxWarning":false,"name":"LORVOTUZUMAB MERTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUN901-DM1, BB-10901","IMGN-901","Lorvotuzumab mertansine"],"count":8,"linkedTargets":{"rows":["ENSG00000149294"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000702","EFO_0002918","EFO_0009052","EFO_0001378","EFO_0000760","EFO_0001376","EFO_0000621","Orphanet_654"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1788399","drugType":"Small molecule","blackBoxWarning":false,"name":"COPPER OLEINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Copper oleinate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1877495","canonicalSmiles":"CC(NNC(=O)c1ccccc1)c1ccccc1","inchiKey":"BEWNZPMDJIGBED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENMOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benmoxin","Mebamoxine"],"crossReferences":{"PubChem":["144205441","29216229"],"drugbank":["DB09246"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1882461","canonicalSmiles":"C[N+]1(C)CCCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"UHUMRJKDOOEQIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevonium"],"crossReferences":{"PubChem":["50112676"],"drugbank":["DB13542"]},"childChemblIds":["CHEMBL2106080"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190","canonicalSmiles":"Cn1c(=O)c2nc[nH]c2n(C)c1=O","inchiKey":"ZFXYFBGIUFBOJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE","yearOfFirstApproval":1940,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","NSC-2066","Theophylline","Theophylline melting point standard","Theophylline monohydrate"],"crossReferences":{"DailyMed":["aminophylline","theophylline"],"PubChem":["104171361","144204378","144209573","144210348","170466874","17389715","174007168","50103998","56463437","68760","855679","90341676"],"TG-GATEs":["96"],"Wikipedia":["Theophylline"],"drugbank":["DB00277"],"chEBI":["28177"]},"childChemblIds":["CHEMBL1355736","CHEMBL1200434","CHEMBL2104089","CHEMBL2107084","CHEMBL1370561"],"count":17,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000282608","ENSG00000065989","ENSG00000128271","ENSG00000105650","ENSG00000163485","ENSG00000170425","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":10},"linkedDiseases":{"rows":["EFO_0009686","Orphanet_79443","EFO_0001361","EFO_0003086","MONDO_0002009","HP_0001919","EFO_0000222","EFO_1000782","EFO_1002048","EFO_0003060","HP_0002315","EFO_0001663","Orphanet_665","HP_0002110","EFO_0000565","MONDO_0001187","HP_0006536","MONDO_0002050","EFO_0000270","EFO_0003884","EFO_0000341","EFO_0003917","EFO_0000763","HP_0002104","EFO_0009492"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1940 and is indicated for airway obstruction and asthma and has 15 investigational indications."}
{"id":"CHEMBL190170","canonicalSmiles":"CC(C)c1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"OQCFORGSZJSAEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07871"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19215","canonicalSmiles":"CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21","inchiKey":"WZHJKEUHNJHDLS-QTGUNEKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METERGOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Liserdol"],"synonyms":["FI 6337","MCE","Metergoline"],"crossReferences":{"PubChem":["104171342","124882907","124882908","144204359","170466571","26751517","26751518","50104076","50104077","50104078","56422452","85231339","855801","90341228"],"Wikipedia":["Metergoline"],"drugbank":["DB13520"],"chEBI":["64216"]},"childChemblIds":["CHEMBL1276418"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2021422","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1OCOP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"LWYLQNWMSGFCOZ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSPROPOFOL DISODIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201766","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquavan","Lusedra"],"synonyms":["Fospropofol disodium","Fospropofol disodium salt","Fospropofol sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and has 1 investigational indication."}
{"id":"CHEMBL2104482","canonicalSmiles":"O=Cc1c(O)cccc1OCc1ccc(C(=O)O)cc1","inchiKey":"XEDONBRPTABQFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCARESOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["589-C","589C","Tucaresol"],"crossReferences":{"drugbank":["DB13027"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104528","canonicalSmiles":"CCCCCCC(C)NN","inchiKey":"FODQIVGFADUBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTAMOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octamoxin"],"crossReferences":{"drugbank":["DB09249"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104708","canonicalSmiles":"C[N+](C)(C)NCCC(=O)[O-]","inchiKey":"PVBQYTCFVWZSJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELDONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meldonium"],"crossReferences":{"drugbank":["DB13723"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104992","canonicalSmiles":"CS(=O)(=O)O.Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"BHECXGHXWKHZOY-DXPOFMJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESTIPITANT MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL522987","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW597588B","Vestipitant mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105199","canonicalSmiles":"O=C(c1ccccn1)c1cnn2c(-c3ccncc3)ccnc12","inchiKey":"OQJFBUOFGHPMSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCINAPLON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL 273,547","Ocinaplon"],"crossReferences":{"drugbank":["DB06529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105458","canonicalSmiles":"CN1CCC(N(Cc2cccs2)c2ccccc2)CC1","inchiKey":"KLOHYVOVXOUKQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THENALIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Hematological toxicity"],"year":1960},"tradeNames":[],"synonyms":["Thenalidine"],"crossReferences":{"PubChem":["144206868"],"drugbank":["DB04826"]},"count":2,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0003785"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pruritus and allergy. It was withdrawn in United States  in 1960 due to Hematological toxicity."}
{"id":"CHEMBL2105500","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2ccccn2)cc1.[Na+]","inchiKey":"DAINBAXHBFSNCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPYRIDINE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL700","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfapyridine sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105642","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[K+]","inchiKey":"FOFFPEFVSRGLOZ-JIDHJSLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE POTASSIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esomeprazole potassium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106274","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2CCC[C@H]3[C@H]1C5","inchiKey":"LNNWVNGFPYWNQE-GMIGKAJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desomorphine"],"crossReferences":{"drugbank":["DB01531"]},"childChemblIds":["CHEMBL3228684"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107016","canonicalSmiles":"CN1C(=O)C[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O","inchiKey":"LQZAIAZUDWIVPM-SRVKXCTJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TALTIRELIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taltirelin"],"crossReferences":{"PubChem":["144206235"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107818","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"OBMJQRLIQQTJLR-USGQOSEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDOXORUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Inno-206"],"synonyms":["Aldoxorubicin"],"crossReferences":{"drugbank":["DB06013"]},"childChemblIds":["CHEMBL2107827"],"count":6,"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","Orphanet_178","EFO_1001480","EFO_0002517","EFO_0000182","MONDO_0007254","EFO_0000702","EFO_1001968","EFO_0000707","EFO_0000519","EFO_0003060"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108063","drugType":"Antibody","blackBoxWarning":false,"name":"ZANOLIMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Humax-cd4"],"synonyms":["HuMax-CD4","MDX-016","Zanolimumab"],"count":5,"linkedTargets":{"rows":["ENSG00000010610"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002913","EFO_0000574","EFO_1001051","EFO_1000785"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108313","drugType":"Protein","blackBoxWarning":false,"name":"CONBERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Conbercept","KH-902"],"count":5,"linkedTargets":{"rows":["ENSG00000150630","ENSG00000119630","ENSG00000112715","ENSG00000173511"],"count":4},"linkedDiseases":{"rows":["EFO_1000880","EFO_0004683","EFO_0001365","EFO_0004207","EFO_1001157","EFO_0009322","EFO_0005773","EFO_0009321"],"count":8},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108559","drugType":"Unknown","blackBoxWarning":false,"name":"SENNOSIDES","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gentle nature","Glysennid"],"synonyms":["Sennoside","Sennosides"],"crossReferences":{"DrugCentral":["4307"]},"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108577","drugType":"Cell","blackBoxWarning":false,"name":"BELAGENPUMATUCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lucanix"],"synonyms":["Belagenpumatucel-l"],"count":2,"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108775","drugType":"Unknown","blackBoxWarning":false,"name":"PODOPHYLLUM RESIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Podoph","Podoph co"],"synonyms":["Podophyllin","Podophyllum resin"],"crossReferences":{"DrugCentral":["5114"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108790","drugType":"Antibody","blackBoxWarning":false,"name":"TELIMOMAB ARITOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T101","Telimomab aritox"],"count":1,"linkedTargets":{"rows":["ENSG00000110448"],"count":1},"linkedDiseases":{"rows":["EFO_0004197"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108818","drugType":"Antibody","blackBoxWarning":false,"name":"YTTRIUM Y 90 LABETUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cea-cide"],"synonyms":["90Y-HMN-14","Labetuzumab 90y","Yttrium y 90 labetuzumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108833","drugType":"Protein","blackBoxWarning":false,"name":"AVOTERMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avotermin"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109143","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL POLISTIREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metaproterenol polistirex"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109168","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"DEXTRAN 40","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gentran 40"],"synonyms":["Dextran 40","LMD","LMWD"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110962","canonicalSmiles":"CC(Cc1ccccc1)NCCCCl","inchiKey":"XXVROGAVTTXONC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEFENOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mefenorex"],"crossReferences":{"PubChem":["170465601"],"drugbank":["DB13852"]},"childChemblIds":["CHEMBL2106838"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2147475","canonicalSmiles":"COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OC[C@H](OP(=O)(O)O)C1CC1","inchiKey":"YDTUJCNTIMWHPJ-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-830216","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-830216","Bms-830216"],"crossReferences":{"drugbank":["DB14787"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL22077","canonicalSmiles":"CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12","inchiKey":"MFZWMTSUNYWVBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYCANTHONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hycanthone","WIN 24,933"],"crossReferences":{"PubChem":["104171314","11112528","11533028","144204082","170466535","26748752","26748753","423107","50122910","56424135"],"Wikipedia":["Hycanthone"],"drugbank":["DB14061"],"chEBI":["52768"]},"childChemblIds":["CHEMBL1983709"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221722","canonicalSmiles":"NC(=O)c1nc(F)cnc1O","inchiKey":"ZCGNOVWYSGBHAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAVIPIRAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Favipiravir","T-705"],"crossReferences":{"drugbank":["DB12466"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL224060","canonicalSmiles":"Cn1nnc2ccc([C@H](c3ccc(Cl)cc3)n3cncn3)cc21","inchiKey":"XLMPPFTZALNBFS-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rivizor"],"synonyms":["R 83842","Vorozole"],"crossReferences":{"Wikipedia":["Vorozole"],"drugbank":["DB13767"]},"childChemblIds":["CHEMBL1668497"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL225072","canonicalSmiles":"Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1","inchiKey":"WBXPDJSOTKVWSJ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMETREXED","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"crossReferences":{"DailyMed":["pemetrexed%20disodium"],"PubChem":["124893263","124950689","525786"],"Wikipedia":["Pemetrexed"],"drugbank":["DB00642"],"chEBI":["63616"]},"childChemblIds":["CHEMBL2360464","CHEMBL3989962"],"count":52,"approvedIndications":["EFO_0000616","EFO_0000588","EFO_0000770","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000176890","ENSG00000228716","ENSG00000159131"],"count":3},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0000637","EFO_0000365","EFO_0000571","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000308","EFO_0000228","EFO_1001951","Orphanet_178","EFO_0000178","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0008528","EFO_0002618","MONDO_0002108","MONDO_0008170","EFO_1000157","EFO_0002939","MONDO_0008315","EFO_0009708","MONDO_0002691","EFO_1000576","MONDO_0015917","EFO_0004284","EFO_0000233","EFO_0000574","EFO_0006544","EFO_1001901","MONDO_0021117","MONDO_0015686","MONDO_0044887","MONDO_0004192","MONDO_0007254","EFO_1001012","EFO_0000708","EFO_0004252","MONDO_0002087","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0003860","EFO_0000770","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","Orphanet_59305","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_1000124","EFO_0000311","EFO_0003863","EFO_1000581","MONDO_0002586","EFO_0006861","MONDO_0011962","EFO_0000702","EFO_0004142","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0003050"],"count":69},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 48 investigational indications."}
{"id":"CHEMBL227634","canonicalSmiles":"[11CH3]NC[C@H](O)c1ccc(O)c(O)c1","inchiKey":"UCTWMZQNUQWSLP-UTDSSMFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]EPINEPHRINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL679","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[11C]-Epinephrine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228224","canonicalSmiles":"Cc1n[nH]cc1-c1ccc(CCN)cc1","inchiKey":"ILTOXASLQDKYJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228224","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2359248","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1","inchiKey":"JKQXZKUSFCKOGQ-QAYBQHTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZEAXANTHIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 161H","E-161H(I)","INS NO.161H(I)","INS-161H(I)","Zeaxanthin"],"crossReferences":{"PubChem":["144206223"],"drugbank":["DB11176"],"chEBI":["27547"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2364656","drugType":"Protein","blackBoxWarning":false,"name":"TOPSALYSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX-302","PRX302","Topsalysin"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2408045","canonicalSmiles":"CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1","inchiKey":"DFJSJLGUIXFDJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8931","AZD8931","Azd-8931","Sapitinib"],"crossReferences":{"PubChem":["174006599"],"drugbank":["DB12183"]},"count":5,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001480","EFO_0000365","MONDO_0007254","MONDO_0024880","EFO_0003060","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL259728","canonicalSmiles":"CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC","inchiKey":"CFRPSFYHXJZSBI-DHZHZOJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITENPYRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205895","170466859"],"drugbank":["DB11438"],"chEBI":["39170"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL266800","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=NCCO3)cc2)on1","inchiKey":"IWZDYGHUSXWPPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL266800","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08720"],"chEBI":["10028"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267476","canonicalSmiles":"CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)O","inchiKey":"OYHQOLUKZRVURQ-HZJYTTRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINOLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3380, LINOLEIC ACID-","Linoleic acid","NSC-281243","Octadeca-9,12-Dienoic Acid"],"crossReferences":{"PubChem":["144204618","144209369","144213397","17388946","26752888"],"Wikipedia":["Linoleic_acid"],"drugbank":["DB14104"],"chEBI":["17351"]},"childChemblIds":["CHEMBL3122088","CHEMBL571449"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL279865","canonicalSmiles":"CCC(=O)OC1(c2ccccc2)CCN(C)CC1","inchiKey":"BCQMRZRAWHNSBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL279865","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Desmethylprodine"],"drugbank":["DB01478"]},"childChemblIds":["CHEMBL3188300"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280074","canonicalSmiles":"Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21","inchiKey":"GTVPOLSIJWJJNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLOMOUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olomoucine","Olomucine"],"crossReferences":{"PubChem":["103905126","11111567","11114014","124880964","124880967","124880968","26752151","26752152","26752153","50104796","50104797","511554","85231165","90340618"],"drugbank":["DB02116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303934","canonicalSmiles":"COc1cc(OC)cc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1","inchiKey":"OARVXDFNTLYMCJ-JVUUKAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303934","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137341","drugType":"Cell","blackBoxWarning":false,"name":"SEVIPROTIMUT-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["POL-103A","Seviprotimut l","Seviprotimut-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137344","drugType":"Enzyme","blackBoxWarning":false,"name":"LATIGLUTENASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALV-003","ALV003","Latiglutenase"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL313833","canonicalSmiles":"NC1CC1c1ccccc1","inchiKey":"AELCINSCMGFISI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANYLCYPROMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006850","90340789"],"drugbank":["DB00752"]},"childChemblIds":["CHEMBL542118"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL314691","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O","inchiKey":"VYCMAAOURFJIHD-PJNXIOHISA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL314691","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12054"],"chEBI":["2965"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3247442","canonicalSmiles":"[3H]C([3H])(CN)c1ccc(O)c(O)c1","inchiKey":"VYFYYTLLBUKUHU-WTJCDBBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3247442","maximumClinicalTrialPhase":0,"parentId":"CHEMBL59","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL342478","canonicalSmiles":"O=C(O)C(=O)Nc1cc2[nH]ccc2cc1C(=O)O","inchiKey":"AHWMERGBWWROMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL342478","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL353955","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1","inchiKey":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYURIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyuridine","Deoxyuridine"],"crossReferences":{"Wikipedia":["Deoxyuridine"],"drugbank":["DB02256"],"chEBI":["16450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545109","drugType":"Small molecule","blackBoxWarning":false,"name":"ARRY-502","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-502","Arry-502"],"count":1,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545177","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-0424","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD0424","Azd-0424"],"count":1,"linkedTargets":{"rows":["ENSG00000097007","ENSG00000197122"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545248","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-7423","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ds-7423"],"count":2,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["MONDO_0011962","EFO_1001951"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545282","drugType":"Small molecule","blackBoxWarning":false,"name":"KC-706","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kc-706"],"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0004719"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707214","canonicalSmiles":"O=C(ON1CCOCC1)c1ccccc1O","inchiKey":"BMOINOKSLLYQQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHOLINE SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morpholine salicylate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707224","canonicalSmiles":"CCOC(=O)C[N+]1(C)CC[C@@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)C1","inchiKey":"SEVCTUCCZYBJER-BSJAROSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFPIRONIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3707223"],"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["HP_0000975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL3707347","canonicalSmiles":"CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(=O)O","inchiKey":"YYBOLPLTQDKXPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERINURAD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RDEA-3170","RDEA3170","Verinurad"],"crossReferences":{"drugbank":["DB11873"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707380","drugType":"Small molecule","blackBoxWarning":false,"name":"RG6029","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0310","Rg6029"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3780740","canonicalSmiles":"COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1.O=S(=O)(O)O","inchiKey":"IFBYQAMJTBOBHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBEGLITAZONE SULFATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3585580","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKD-501","Ckd-501","Lobeglitazone sulfate"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3786896","canonicalSmiles":"CCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCc1cc(Cl)ccc1-n1cnnn1)c1ccc(F)cc1","inchiKey":"YUHNXUAATAMVKD-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-8165","AZD8165","Azd 8165","Azd-8165","Azd8165"],"crossReferences":{"drugbank":["DB15132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3945728","canonicalSmiles":"O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1","inchiKey":"SQZJGTOZFRNWCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-1431","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-1431","Abx-1431"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3984979","canonicalSmiles":"Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1.Cl","inchiKey":"NCQCOWCHUPYWFZ-ZJULCNDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3984979","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3787344","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989451","canonicalSmiles":"CCC[C@@](C)(O)[C@H]1C[C@@]23C=C[C@]1(OC)[C@@H]1Oc4c(OC(C)=O)ccc5c4[C@@]12CCN(C)[C@@H]3C5","inchiKey":"LFYBMMHFJIAKFE-PMEKXCSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetorphine","Acetylpropylorvinol"],"crossReferences":{"drugbank":["DB01469"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989697","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)([O-])O)c2cc1C.O.O.[Na+]","inchiKey":"LQVGUKOCMOKKJU-QPVGXXQTSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOFLAVIN 5'-PHOSPHATE SODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201794","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Photrexa"],"synonyms":["Phosphated riboflavin","Riboflavin 5'-phosphate sodium","Riboflavin sodium phosphate"],"crossReferences":{"DailyMed":["riboflavin%205'-phosphate%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL3989934","canonicalSmiles":"Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O","inchiKey":"RSNPAKAFCAAMBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVADOMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avadomide","CC-122","CC122"],"crossReferences":{"drugbank":["DB14857"]},"childChemblIds":["CHEMBL3989913"],"count":7,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3989972","canonicalSmiles":"COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O","inchiKey":"KVHRYLNQDWXAGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALIPODECT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balipodect","TAK-063"],"crossReferences":{"drugbank":["DB14774"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL404150","canonicalSmiles":"NCCc1ccc(O)c(C2CCCCC2)c1","inchiKey":"DOCCSEDGBYCYLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL404150","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07345"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4088896","canonicalSmiles":"C[C@H](CN1CCOCC1)n1/c(=N\\C(N)=O)[nH]c2cc(/C=C3\\c4ccccc4COc4cc(F)ccc43)ccc21","inchiKey":"YPCLDHGBEKZGEB-RUDKWAFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4088896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL42055","canonicalSmiles":"OCCN1CCN(CC/C=C2\\c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"NJMYODHXAKYRHW-BLLMUTORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-FLUPENTIXOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-flupentixol","Flupenthixol","Flupentixole"],"crossReferences":{"PubChem":["11111164","11111165"],"Wikipedia":["Flupentixol"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL42710","canonicalSmiles":"C=CCc1ccc(O)c(OC)c1","inchiKey":"RRAFCDWBNXTKKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUGENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eugenol"],"crossReferences":{"PubChem":["144204685","144209238","144210425","170465464","17389879","26747361","26753011","50105594"],"Wikipedia":["Eugenol"],"drugbank":["DB09086"],"chEBI":["4917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4283439","canonicalSmiles":"CCOc1ccc2c(c1)[C@]1(CC[C@H](OCCN3CCOCC3)CC1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC","inchiKey":"QKXJWFOKVQWEDZ-VCCCEUOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4283439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14923"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4291143","canonicalSmiles":"Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C(=O)N3CCc4cc(C(=O)Nc5c(C)cccc5F)sc4-c4ccccc43)cc2)c1","inchiKey":"VTCJNYICQADBJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PC-786","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PC-786","PC786","Pc-786","Pc786"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297295","canonicalSmiles":"O=C(NCc1ccc(OC(F)(F)F)c(F)c1)[C@H]1CN(c2nc3nc(C4CC4)ncc3s2)CCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1","inchiKey":"JQLOVYLALGSISI-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JTK-853","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jtk-853"],"crossReferences":{"drugbank":["DB13095"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297303","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C1CCCC1)NC(=O)O[C@@H]1CCC[C@H]1CCCCCn1c(nc3cc(OC)ccc3c1=O)O2)C(=O)NS(=O)(=O)C1(C)CC1","inchiKey":"HMYVZDWJFQOHCD-XEZGQWAWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2748","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK2748","Mk-2748"],"crossReferences":{"drugbank":["DB15371"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297431","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1F","inchiKey":"HYTPDMFFHVZBOR-VNXMGFANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HENAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Henagliflozin","SHR-3824","SHR3824","Shr3824"],"crossReferences":{"drugbank":["DB11939"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297492","canonicalSmiles":"CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1","inchiKey":"LFMPVTVPXHNXOT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2245035","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2245035","GSK2245035","Gsk-2245035","Gsk2245035"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297561","drugType":"Unknown","blackBoxWarning":false,"name":"EPI-589","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPI-589","Epi-589"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297656","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\\CCCCCCCC)OC(=O)CCCCCCC/C=C\\CCCCCCCC","inchiKey":"PHYFQTYBJUILEZ-IUPFWZBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL TRIOLEATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glyceryl trioleate","Triolein"],"crossReferences":{"drugbank":["DB13038"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297688","drugType":"Unknown","blackBoxWarning":false,"name":"ADU-S100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADU-S100","Adu s100","Adu-s100","CDN AGONIST ADU-S100","MIW815","MW-815","Miw815"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297890","drugType":"Unknown","blackBoxWarning":false,"name":"ARC-19499","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARC19499","Arc-19499","Arc19499","BAX-499","BAX499"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297916","drugType":"Unknown","blackBoxWarning":false,"name":"BNC-105P","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bnc-105p","Bnc105p"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297968","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-3174998","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-3174998","GSK3174998","Gsk 3174998","Gsk-3174998","Gsk3174998"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL454801","canonicalSmiles":"COC1=C(OC)C(=O)C(C/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)=C(C)C1=O","inchiKey":"ACTIUHUUMQJHFO-UPTCCGCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UBIDECARENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["API 31510","API-31510","NSC-140665","NSC-140865","Ubidecarenone","Ubidecarenone for system suitability","Ubiquinone 50"],"crossReferences":{"PubChem":["144205213","29215368"],"Wikipedia":["Coenzyme_Q10"],"drugbank":["DB09270"],"chEBI":["46245"]},"count":27,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 27 investigational indications."}
{"id":"CHEMBL458616","canonicalSmiles":"OCCCCCCO","inchiKey":"XXMIOPMDWAUFGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,6-HEXANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,6-Hexanediol"],"crossReferences":{"PubChem":["144207648"],"Wikipedia":["1,6-Hexanediol"],"drugbank":["DB02210"],"chEBI":["43078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594217","canonicalSmiles":"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O","inchiKey":"RCCZPUWDQVUJAB-FVYJGOGTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANAGLIFLOZIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2048484","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invokana"],"synonyms":["Canagliflozin","Canagliflozin hemihydrate","Canagliflozin hydrate","JNJ-24831754-ZAE","JNJ-28431754","JNJ-28431754-AAA","TA-7284"],"crossReferences":{"DailyMed":["canagliflozin"]},"count":7,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003144","EFO_0000401","EFO_0001359","EFO_0004194","EFO_0001360","EFO_0001073","EFO_0000400"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594253","canonicalSmiles":"Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"ZVPYVZMKBQYKQG-ZVWHLABXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVAVOTINIB CITRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3979920","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mivavotinib citrate","TAK-659","Tak 659","Tak-659"],"count":6,"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0001075","MONDO_0044889","EFO_0000403","EFO_0000574","EFO_0000222","MONDO_0018906","EFO_0005952"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4594456","drugType":"Unknown","blackBoxWarning":false,"name":"AK-104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-104","AK104","Ak-104","Ak104"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594507","drugType":"Unknown","blackBoxWarning":false,"name":"TRANSCON CNP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Transcon cnp"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594513","drugType":"Antibody","blackBoxWarning":false,"name":"SAMROTAMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-085","Abbv-085","PR-1498487 PAB-MMAE","Samrotamab vedotin"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594546","drugType":"Antibody","blackBoxWarning":false,"name":"TELAZORLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 830","GBR-830","GBR830","Gbr 830","ISB 830","ISB-830","Telazorlimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594555","drugType":"Unknown","blackBoxWarning":false,"name":"DEXTRAN SULFATE SODIUM (5000 MW)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextran sulfate sodium (5000 mw)","Ibsolvmir"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL461806","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)O)c2)c1O.NCCO","inchiKey":"LQQUHOUXABUDJA-OUFJFOJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELTROMBOPAG OLAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL461101","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Promacta"],"synonyms":["Eltrombopag olamine","Promacta","Revolade"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL476960","canonicalSmiles":"OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZNCGRZWXLXZSZ-CIQUZCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOGLIBOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Basen","Glustat"],"synonyms":["A-71100","AO-128","Voglibose"],"crossReferences":{"PubChem":["144205773","170465993"],"Wikipedia":["Voglibose"],"drugbank":["DB04878"]},"count":2,"linkedTargets":{"rows":["ENSG00000171298","ENSG00000090402","ENSG00000257335","ENSG00000257743"],"count":4},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400","EFO_0002546"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL48046","canonicalSmiles":"COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cccc(CN)c2)cc1","inchiKey":"XFKVLKLCLYJKNF-MZNJEOGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04424"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL486174","canonicalSmiles":"CCCC[C@@H](O)/C=C(C)/C=C/C=C/C(=O)N1CCCC1=O","inchiKey":"ZYPGADGCNXOUJP-CXVPHVKISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PECILOCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pecilocin","Variotin"],"crossReferences":{"Wikipedia":["Pecilocin"],"drugbank":["DB13459"],"chEBI":["32289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL487465","canonicalSmiles":"COCCOCCOCCOc1cccc(C2=N[C@@](C)(C(=O)O)CS2)c1O","inchiKey":"AWHIMFSHNAAMBM-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFERITAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fbs0701, spd602"],"synonyms":["Deferitazole","FBS-0701","FBS0701","SPD-602","SPD602"],"crossReferences":{"drugbank":["DB13120"]},"childChemblIds":["CHEMBL495105"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL493636","canonicalSmiles":"CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"GWBPFRGXNGPPMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFANITRAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfanitran"],"crossReferences":{"PubChem":["144204954","170466141","26748787"],"drugbank":["DB11463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL494708","canonicalSmiles":"CCCCC/C=C/CC(C/C=C/CCCCC)(P(=O)(O)O)P(=O)(O)O","inchiKey":"PFKBXXKNHWTTCS-PHEQNACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BPH-798","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPH-798"],"crossReferences":{"drugbank":["DB08529"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL503","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21","inchiKey":"PCZOHLXUXFIOCF-BXMDZJJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOVASTATIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Altoprev","Lovastatin","Mevacor","Mevinacor","Mevinacor 10","Mevinacor 40"],"synonyms":["C10AA02","L-154803","Lovastatin","MK-803","Mevinolin","Simvastatin impurity, lovastatin-"],"crossReferences":{"DailyMed":["lovastatin"],"PubChem":["144204439","144208673","144210588","170464913","17389841","26751557","496591","49732779","855905"],"Wikipedia":["Lovastatin"],"drugbank":["DB00227"],"chEBI":["40303"]},"count":29,"approvedIndications":["HP_0003124","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","Orphanet_909","EFO_0000756","MONDO_0007254","EFO_0003876","Orphanet_778","HP_0100543","EFO_1001375","EFO_0000712","MONDO_0004681","EFO_1000757","Orphanet_2745","EFO_0000685","Orphanet_46724","HP_0003124","EFO_0002508","MONDO_0008170","Orphanet_636","EFO_0000222","EFO_0000319","MONDO_0008315","EFO_0002615","Orphanet_908","Orphanet_309005","EFO_0000589","MP_0001845","EFO_0000270","EFO_0000764","EFO_0000341","EFO_1000860"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for cardiovascular disease and hypercholesterolemia and has 27 investigational indications."}
{"id":"CHEMBL516023","canonicalSmiles":"NC(=O)c1cccc(Cn2c3c(c4cccc(C(=O)O)c42)CCCCC3)c1","inchiKey":"GKBQRPKZHUFGOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL516023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL537885","canonicalSmiles":"Cl.Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1","inchiKey":"LEPNDALFXHAENA-UOERWJHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL537885","maximumClinicalTrialPhase":0,"parentId":"CHEMBL141","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL541521","canonicalSmiles":"CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl","inchiKey":"IYBQHJMYDGVZRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIDOCAINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL79","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lidocaine HCl"],"crossReferences":{"PubChem":["50106479","855603"],"chEBI":["50512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL551064","canonicalSmiles":"Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1","inchiKey":"USVCWSAJUAARAL-MEMLXQNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AEW-541","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aew-541","NVP-AEW541"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL551561","canonicalSmiles":"CSC[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"WBPLMFVTQMIPLW-MFYTUXHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL551561","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL557555","canonicalSmiles":"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O","inchiKey":"KPSRODZRAIWAKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPROFIBRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modalim"],"synonyms":["Ciprofibrate","WIN 35833","WIN-35833"],"crossReferences":{"PubChem":["144205674","144208557","144213157","170466356","26757866","50105908","56463556","85230953","90340632"],"Wikipedia":["Ciprofibrate"],"drugbank":["DB09064"],"chEBI":["50867"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL606258","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]3(CO3)C[C@H](C)[C@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@H]2C)O[C@@H](C)[C@@H]1O","inchiKey":"RZPAKFUAFGMUPI-QESOVKLGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEANDOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E704","Oleandomycin"],"crossReferences":{"Wikipedia":["Oleandomycin"],"drugbank":["DB11442"],"chEBI":["16869"]},"childChemblIds":["CHEMBL2105788"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL620","canonicalSmiles":"C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2","inchiKey":"HOOSGZJRQIVJSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIDINIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clidinium"],"crossReferences":{"DailyMed":["clidinium%20bromide"]},"childChemblIds":["CHEMBL1200950"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL641","canonicalSmiles":"CNCC[C@@H](Oc1ccccc1C)c1ccccc1","inchiKey":"VHGCDTVCOLNTBX-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATOMOXETINE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atomoxetine","Strattera"],"crossReferences":{"DailyMed":["atomoxetine%20hydrochloride"],"PubChem":["11114266"],"Wikipedia":["Atomoxetine"],"drugbank":["DB00289"],"chEBI":["127342"]},"childChemblIds":["CHEMBL1702"],"count":19,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0000249","EFO_0005252","EFO_0003768","EFO_0003757","EFO_1001917","EFO_0003829","EFO_0007191","HP_0100543","MONDO_0002050","HP_0001575","EFO_1000645","EFO_0004701","EFO_0005230","EFO_0003877","EFO_0000692","EFO_0003888","EFO_0005203","HP_0010865","EFO_0002508","EFO_0003758","EFO_0000311","EFO_0003890","MONDO_0002491","EFO_0004895","EFO_0001359","EFO_0005611","EFO_0003918","EFO_0005411"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for attention deficit hyperactivity disorder and has 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL677","canonicalSmiles":"C[C@H](N)[C@H](O)c1ccc(O)c(O)c1","inchiKey":"GEFQWZLICWMTKF-CDUCUWFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVONORDEFRIN","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-cobefrin"],"synonyms":["Corbadrine","Levonordefrin","Neo-Cobefrin","Nordefrin"],"crossReferences":{"DailyMed":["levonordefrin"],"PubChem":["11111073","11112447","144205604","170464794"],"Wikipedia":["Levonordefrin"],"drugbank":["DB06707"],"chEBI":["10304"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL7301","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1","inchiKey":"AKJHMTWEGVYYSE-FXILSDISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENRETINIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-HPR","Fenretinide","MCN-R-1967"],"crossReferences":{"PubChem":["144204558","144208187","170466359","17389243","26752780","26752781","26752782","26752783","49718105","50105427","50105428","50105430","577595","90341414","92763796"],"Wikipedia":["Fenretinide"],"drugbank":["DB05076"],"chEBI":["42588"]},"count":22,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL74","canonicalSmiles":"O=C([O-])c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)[O-])cc(=O)c34)cccc2o1.[Na+].[Na+]","inchiKey":"VLARUOGDXDTHEH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CROMOLYN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL428880","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerocrom","Allercrom","Aspire","Brol-eze","Catacrom","Clariteyes","Crolom","Cromogen","Cromogen e-breathe","Cromolux","Cromolyn sodium","Cromoptic","Cromosol","Cromosol optha","Cusilyn","Dominion pharma hayfever","Eye-crom","Gastrocrom","Glycavent","Gppe syncroner inha","Hay-crom","Intal","Intal 5","Lomudal","Lomusol","Murine","Nalcrom","Nasalcrom","Opticrom","Opticrom aq","Resiston one","Resiston treatment pack","Rynacrom","Rynacrom allergy","Rynacrom co","Steri-neb cromogen","Vivicrom","Vividrin","Viz-on"],"synonyms":["Cromoglicate sodium","Cromoglycic acid","Cromolyn","Cromolyn disodium salt","Cromolyn sodium","FPL-670","FPL.670","NSC-109500","Sodium cromoglicate"],"crossReferences":{"DailyMed":["cromolyn%20sodium"],"PubChem":["11112999","124882750","144204414","144212320","170464887","26747950","855804"],"Wikipedia":["Cromoglicic_acid"],"chEBI":["128458"]},"count":3,"approvedIndications":["EFO_0000270"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for asthma and has 2 investigational indications."}
{"id":"CHEMBL75691","canonicalSmiles":"Clc1ccc(-c2cc(C3CCNCC3)[nH]n2)cc1","inchiKey":"GELALLNTKKLQLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL75691","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817352"],"drugbank":["DB08061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL843","canonicalSmiles":"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SUFUKZSWUHZXAV-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROSIGLITAZONE MALEATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL121","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"classes":["Cardiotoxicity"],"year":2010},"tradeNames":["Avandia","Rosiglitazone maleate"],"synonyms":["Avandia","BRL-49653","BRL-49653-C","BRL-49653C","Rosiglitazone maleate"],"crossReferences":{"DailyMed":["rosiglitazone%20maleate"],"PubChem":["144212684","49681563"],"chEBI":["8892"]},"count":12,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0006859","HP_0002745","EFO_0002614","EFO_0000764","EFO_1001249","EFO_0000373","EFO_1001110","EFO_0001360","EFO_0000400","EFO_0000691","EFO_1000158"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 10 investigational indications. It was withdrawn in European Union  in 2010 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL88712","canonicalSmiles":"O=C(O)[C@@H](c1ccc(OCc2ccc3ccccc3n2)cc1)C1CCCC1","inchiKey":"ZEYYDOLCHFETHQ-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELIFLAPON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY X 1005","BAY-X-005","BAY-X-1005","DG-031","Veliflapon"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL908","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"WSPOMRSOLSGNFJ-AUWJEWJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROTHIXENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Taractan","Truxal"],"synonyms":["Chlorprothixene","N-714","N-714RO 4-0403","NSC-18720","RO 4-0403","RO-4-0403","RO-40403"],"crossReferences":{"PubChem":["26665646","29217891"],"Wikipedia":["Chlorprothixene"],"drugbank":["DB01239"],"chEBI":["50931"]},"childChemblIds":["CHEMBL1256658"],"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":4},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL96172","canonicalSmiles":"C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1","inchiKey":"XOZIUKBZLSUILX-GIQCAXHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPOTHILONE D","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epothilone d","KOS-862","NSC-703147","R-1492","R1492"],"crossReferences":{"PubChem":["527930"],"drugbank":["DB01873"],"chEBI":["29579"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL994","canonicalSmiles":"COc1cc(NC(C)CCCN)c2ncccc2c1.O=P(O)(O)O","inchiKey":"RKFFPTPBADAVDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL994","maximumClinicalTrialPhase":0,"parentId":"CHEMBL506","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["431058","489497","56320916","56463673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL99668","canonicalSmiles":"N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12","inchiKey":"XOKJUSAYZUAMGJ-WOUKDFQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOYOCAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
